Yizhan Guo

6PUBLICATIONS
23CO-AUTHORS
Predictive and prognostic markersLiquid biopsiesEpidemiological modellingInnate immunityTransplantation immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Nov 13, 2025
Utilization and outcomes of lung transplant from donors with cancer: a UNOS study.

Yizhan Guo, Kentaro Noda, Masashi Furukawa

|Aug 21, 2024
Stress-induced eosinophil activation contributes to postoperative morbidity and mortality after lung resection.

Zhongcheng Mei, May A Khalil, Yizhan Guo

|May 05, 2022
Ischemia reperfusion injury facilitates lung allograft acceptance through IL-33-mediated activation of donor-derived IL-5 producing group 2 innate lymphoid cells.

Yizhan Guo, Zhongcheng Mei, Dongge Li

|Jul 07, 2019
Vendor-specific microbiome controls both acute and chronic murine lung allograft rejection by altering CD4+ Foxp3+ regulatory T cell levels.

Yizhan Guo, Qing Wang, Dongge Li

|Jan 27, 2017
Deficiency of the adaptor protein SLy1 results in a natural killer cell ribosomopathy affecting tumor clearance.

Saeed Arefanian, Daniel Schäll, Stephanie Chang

Pageof 1